News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
762,603 Results
Type
Article (50961)
Company Profile (390)
Press Release (711252)
Section
Business (224664)
Career Advice (2521)
Deals (37974)
Drug Delivery (105)
Drug Development (86621)
Employer Resources (185)
FDA (17263)
Job Trends (16272)
News (377282)
Policy (36271)
Tag
Academia (2915)
Alliances (53325)
Alzheimer's disease (1327)
Approvals (17174)
Artificial intelligence (148)
Bankruptcy (377)
Best Places to Work (12438)
Biotechnology (275)
Breast cancer (130)
Cancer (1174)
Cardiovascular disease (109)
Career advice (2086)
Cell therapy (266)
Clinical research (68548)
Collaboration (418)
Compensation (207)
COVID-19 (2729)
C-suite (106)
Data (1157)
Diabetes (167)
Diagnostics (6643)
Drug pricing (99)
Earnings (94415)
Employer resources (157)
Events (124904)
Executive appointments (326)
FDA (17822)
Funding (373)
Gene therapy (200)
GLP-1 (677)
Government (4988)
Healthcare (20650)
Infectious disease (2823)
Inflammatory bowel disease (121)
Interviews (423)
IPO (17317)
Job creations (4222)
Job search strategy (1788)
Layoffs (475)
Legal (8914)
Lung cancer (188)
Manufacturing (197)
Medical device (14289)
Medtech (14294)
Mergers & acquisitions (20720)
Metabolic disorders (460)
Neuroscience (1632)
NextGen Class of 2024 (7354)
Non-profit (5044)
Northern California (1520)
Obesity (269)
Opinion (227)
Patents (111)
People (61342)
Phase I (21312)
Phase II (30093)
Phase III (22541)
Pipeline (469)
Postmarket research (2807)
Preclinical (9256)
Radiopharmaceuticals (259)
Rare diseases (244)
Real estate (6627)
Regulatory (23782)
Research institute (2589)
Resumes & cover letters (430)
Southern California (1343)
Startups (3942)
United States (14272)
Vaccines (637)
Weight loss (212)
Date
Today (147)
Last 7 days (786)
Last 30 days (4016)
Last 365 days (38083)
2024 (34940)
2023 (42515)
2022 (53800)
2021 (58583)
2020 (57562)
2019 (51145)
2018 (38698)
2017 (35346)
2016 (35477)
2015 (41543)
2014 (35747)
2013 (30726)
2012 (32716)
2011 (33384)
2010 (31939)
Location
Africa (889)
Arizona (214)
Asia (44241)
Australia (7365)
California (3460)
Canada (1307)
China (261)
Colorado (154)
Connecticut (163)
Europe (98755)
Florida (474)
Georgia (126)
Illinois (390)
Indiana (210)
Kansas (100)
Maryland (621)
Massachusetts (2781)
Michigan (175)
Minnesota (294)
New Jersey (993)
New York (990)
North Carolina (808)
Northern California (1520)
Ohio (148)
Pennsylvania (859)
South America (1311)
Southern California (1343)
Texas (485)
Washington State (379)
762,603 Results for "20 20 genesystems inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Multiple sclerosis
Study Casts Doubt on Benefit of Anti-CD20 Therapies in Multiple Sclerosis
New research has found that MS patients treated with anti-CD20 antibodies, such as Roche’s Ocrevus, do not experience significantly slower progression of disability.
September 26, 2024
·
2 min read
·
Tristan Manalac
BioForest
RareCyte secures $20M financing to expand the Orion™ Spatial Biology platform including Multiplex Assay Reagents, Software and Precision Biology Services
RareCyte, Inc. announced today the completion of a $20M financing from new and existing investors.
June 27, 2024
·
2 min read
Longeveron® to Present at the Virtual Life Sciences Investor Forum on June 20, 2024
Longeveron Inc. today announced that it will participate in the Virtual Life Sciences Investor Forum taking place June 20, 2024.
June 17, 2024
·
1 min read
Press Releases
Personalis to Participate at Upcoming Investor Conferences - November 20, 2024
November 20, 2024
·
1 min read
Deals
Standard BioTools Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - May 20, 2024
Standard BioTools Inc. today announced that the Human Capital Committee of its Board of Directors, which is composed entirely of independent directors, granted an equity award effective as of May 20, 2024, under the Standard BioTools Inc. 2022 Inducement Equity Incentive Plan (Plan).
May 20, 2024
·
2 min read
Lone Star Bio
VenoStent Completes $20 Million Series A with $4 Million Investment from Norwest Venture Partners
VenoStent, Inc. announced that it closed an additional $4 million from Norwest Venture Partners to round out its Series A financing at $20 million with Good Growth Capital and IAG Capital Partners co-leading the deal.
June 27, 2024
·
4 min read
BioCapital
Incyte Announces Intention to Buy Back up to $2.0 Billion of its Common Stock
Incyte Corporation announced that its Board of Directors approved a share repurchase authorization of $2.0 billion.
May 13, 2024
·
9 min read
Press Releases
CIRM Marks 20 Years of Advancing Regenerative Medicine in California
November 15, 2024
·
3 min read
Biotech Beach
Xencor Regains CD20 x CD3 Bispecific T-Cell Engager
Xencor, Inc. announced it will regain exclusive worldwide rights to plamotamab, a CD20 x CD3 bispecific T-cell engager, which Xencor advanced through Phase 1 clinical development in hematologic cancers.
June 13, 2024
·
5 min read
Press Releases
Advisory Committee on Immunization Practices Recommends PREVNAR 20® (20-Valent Pneumococcal Conjugate Vaccine) for Adults Aged 50 and Older
October 24, 2024
·
11 min read
1 of 76,261
Next
